BackNovo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Current Cash

Novo Nordisk A/S Class B's current cash is $21B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$21.13B
↓ 45.74% YoYΔ $-17.81B vs prior year quarter

Peer average

Loading

Novo Nordisk A/S Class B Current Cash History

Loading

Novo Nordisk A/S Class B vs. peers: Current Cash Comparison

Loading

Novo Nordisk A/S Class B Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novo Nordisk A/S Class B (NONOF) FAQ

The latest current cash for NONOF is $21B as of March 2026. That compares with $39B in the prior-year period — down 45.7% year over year. Investors often review this figure alongside Novo Nordisk A/S Class B's historical trend and sector peers before judging valuation or financial health.

Over the past year, NONOF's current cash moved from $39B to $21B — a 45.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Novo Nordisk A/S Class B's operating scale or balance-sheet position.

A current cash figure of $21B for NONOF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NONOF's current cash ($21B), review year-over-year change from $39B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Novo Nordisk A/S Class B's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.